Review Papers Claim by Claim

 Quick Answer Copied

 Long Answer

Key Findings From a Prospective Design

Mehta et al. recruited 104 non-elite London Marathon runners (2009–2010) and used a two-part design: a matched prospective comparison (Part A) and a multivariate regression on the full heterogeneous cohort (Part B). In Part A, post-race cTnI was significantly lower in the HIGH T-E group (median 0.03 μg/L, IQR 0.02–0.057; n=27) than the LOW T-E first-marathon group (median 0.11 μg/L, IQR 0.03–0.18; n=25; p<0.05), despite the HIGH T-E group finishing ~1 hour faster Primary outcomes: cTnI by training group and regression.

The figure shows medians with IQR whiskers; the LOW T-E interquartile range spans well above the 0.04 μg/L upper reference limit, whereas the HIGH T-E median sits below it.

Interpretation and Mechanistic Context

Only 3-year average weekly mileage predicted cTnI release; recent 4-month mileage, finishing time, and demographics did not — suggesting cumulative adaptation rather than acute fitness drives the apparent protection. The authors propose cytosolic 'leakage' (membrane blebbing, integrin-mediated release, oxidative stress) rather than necrosis, consistent with the rapid 24–48 h return to baseline unlike MI kinetics Proposed release mechanisms in the discussion. Later work complicates this: a Brighton Marathon study found relative exercise intensity (% ventilatory threshold), not self-reported training history, best predicted post-race cTnT (r≈0.5–0.6) Brighton Marathon relative-intensity study.

Critical Appraisal

Strengths: a priori group definitions, matched demographics, and a validated assay with local precision data. Limitations the authors acknowledged: single immediate post-race sampling likely missed peak cTnI; assay floor of 0.02 μg/L prevented precise delta calculations; self-reported 3-year recall invites bias. Unaddressed confounding: HIGH T-E runners ran significantly faster and had lower resting heart rates — cumulative mileage may proxy for relative intensity, an alternative the design cannot exclude given later evidence Counterevidence on training-history mechanism. Regression used log-transformed self-report data without validation, and clinical relevance of sub-clinical troponin elevations remains undefined. What would change the conclusion: serial sampling showing identical peaks across training strata, or objective (GPS/watch-verified) training data nullifying the mileage–cTnI association.

Best Evidence: Training vs IntensityMeta-analysis: Exercise Troponin

 BGPT Paper Review

Study Novelty

First prospective (a priori group-defined) test of training status vs post-exercise troponin release; prior studies were retrospective and equivocal, making the design advance meaningful for 2012.

Scientific Quality

Sound matched-group design and assay validation, but single time-point sampling, assay floor effects, self-reported recall, and uncontrolled finishing-time confounding weaken causal inference.

Study Generality

Findings apply to non-elite marathoners; generalization to elites, other endurance modalities, women (30% of cohort), and clinical populations is untested.

Study Usefulness

Informs interpretation of post-exercise troponin in athletes and frames training history as a modifier, guiding future controlled studies on exercise-induced cardiac biomarker release.

Study Reproducibility

Methods, assay characteristics, and inclusion cut-offs are reported in adequate detail, but no raw data, code, or objective training verification is available; replication depends on self-report fidelity.

Explanatory Depth

Mechanistic discussion (cytosolic leakage, blebbing, integrins) is plausible but speculative; the study establishes association, not mechanism, and cannot separate training adaptation from relative-intensity confounding.